Skip to main content
Premium Trial:

Request an Annual Quote

Pierce Inks Deal with GenTel to Distribute Slides, Use Tech for Protein Arrays

NEW YORK, Oct. 27 (GenomeWeb News) - Pierce Biotechnology, a unit of Fisher Biosciences, will distribute GenTel BioSurfaces's thin-film nitrocellulose slides and has also licensed GenTel technology to develop its onw protein arrays, the companies said yesterday.

 

GenTel's PATH brand slides are specifically designed for protein-array applications and are 50 times thinner than conventional nitrocellulose slides, GenTel said. The slides are also compatible with Pierce chemiluminescent-detection systems.

 

Pierce will use GenTel's technology to build on its SearchLight multiplex protein-profiling system. Microarray systems using GenTel's technology will allow researchers to measure the expression of up to 25 proteins in one experiment, the company said.

 

Additional details were not disclosed.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.